Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared on LinkedIn:
“Global Health Summit 2026
Attended this well‑attended Global Health Summit.
The opening slogan Do good and do well, with love struck a chord. The healthcare industry should pursue business excellence while keeping patient‑centered humanity at its heart.
Key takeaways:
- Healthcare goes beyond treatment – it is about respect, compassion and dignity
- Innovative technologies including cancer therapies, mRNA, AI diagnostics and robotic surgery keep advancing healthcare
Commercial success and human‑centric mission must go hand‑in‑hand.
Hopeful Outlook: China‑Originated
China has delivered impressive strides in pharmaceutical innovation, particularly targeted therapies for cancer.
As Chinese‑originated drugs go global amid complex geopolitical landscapes, the session outlined three thoughtful stances: Do not evade, do not over‑exaggerate, do not misjudge.
- Do not evade: Acknowledge real‑world cross‑border market dynamics openly
- Do not over‑exaggerate: Maintain objectivity on domestic research‑and‑development strengths
- Do not misjudge: Guard against self‑mis‑assessment; differentiate ‘speed‑and‑scale’ from ‘trust‑and‑value’.
Rather than purely chasing rapid expansion, China is positioning itself as a collaborative global partner. Grounded in robust clinical evidence, it seeks to build trusted global value frameworks and co‑create a shared global health community for pharmaceutical innovation.
For lung‑cancer patients worldwide, this collaborative mindset translates into more home‑grown advanced treatment options reaching international markets. It is an encouraging, patient‑centered direction for global healthcare.”
Other articles about Norman Ng on OncoDaily.
